MIDAS Healthcare Solutions Inc. has raised $1.2 million from a development partner for its products that secure, track and dispose of controlled drugs, such as opioids, in health care settings.
That partner, IQ Inc. in Monroeville, Pennsylvania, is developing the software that will run the patent-pending portfolio of MIDAS (medication integrity diversion accountability system) products.
"We hit on a vulnerability in health care," said Jeffrey Wahl, co-founder and president, in an interview.
"There…
